Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00823368 |
Date of registration:
|
13/01/2009 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001
|
Scientific title:
|
Biomarker Testing and DNA Collection in Subjects Participating in a Double-Blind, Placebo-Controlled, Crossover, Flexible-Dose Evaluation of the Efficacy, Safety, and Tolerability of STX209 in the Treatment of Irritability in Subjects With Fragile X Syndrome |
Date of first enrolment:
|
January 2009 |
Target sample size:
|
|
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00823368 |
Study type:
|
Observational |
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
United States
| | | | | | | |
Contacts
|
Name:
|
Craig Erikson, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Riley Hospital for Children |
|
Name:
|
Lawrence Ginsberg, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Red Oaks Psychiatry Associates, PA |
|
Name:
|
Bryan King, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Seattle Children's Hospital |
|
Name:
|
Shivkumar Hatti, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Suburban Research Associates |
|
Name:
|
Jonathan Picker, MBChB, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Children's Hospital Boston |
|
Name:
|
Linmarie Sikich, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of North Carolina Neurosciences Hospital |
|
Name:
|
Ted Brown, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
NYS Institute for Basic Research in Developmental Disabilities |
|
Name:
|
Elizabeth Berry-Kravis, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Rush University Medical Center |
|
Name:
|
Randi Hagerman, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
M.I.N.D. Institute |
|
Name:
|
Raun Melmed, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Southwest Autism Research & Resource Center |
|
Name:
|
James McCracken, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University of California, Los Angeles |
|
Name:
|
Jeremy Veenstra-VanderWeele, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Vanderbilt Kennedy Center |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Subjects that meet the inclusion and exclusion criteria and consent to participate in
protocol 22001
Exclusion Criteria:
- Subjects that meet the inclusion and exclusion criteria and consent to participate in
protocol 22001
Age minimum:
6 Years
Age maximum:
40 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Fragile X Syndrome
|
Intervention(s)
|
Drug: STX209
|
Primary Outcome(s)
|
change in plasma proteins with treatment
[Time Frame: After 4 weeks of treatment]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|